Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers

MLA

Thomas Antoine-Moussiaux, et al. Reactogenicity, Safety and Antibody Response, after One and Two Doses of MRNA-1273 in Seronegative and Seropositive Healthcare Workers. Oct. 2021. EBSCOhost, https://doi.org/10.1016/j.jinf.2021.03.025.

APA

Thomas Antoine-Moussiaux, Laurent Blairon, Ingrid Beukinga, Marie Tré-Hardy, Alexandra Horeanga, Alain Wilmet, Andrea Della Vecchia, Roberto Cupaiolo, Emmanuelle Papleux, & Marc Vekemans. (2021). Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers. https://doi.org/10.1016/j.jinf.2021.03.025

Chicago

Thomas Antoine-Moussiaux, Laurent Blairon, Ingrid Beukinga, Marie Tré-Hardy, Alexandra Horeanga, Alain Wilmet, Andrea Della Vecchia, Roberto Cupaiolo, Emmanuelle Papleux, and Marc Vekemans. 2021. “Reactogenicity, Safety and Antibody Response, after One and Two Doses of MRNA-1273 in Seronegative and Seropositive Healthcare Workers,” October. doi:10.1016/j.jinf.2021.03.025.